ARC152 Investigational CD28-engaging antibody in lead identification for gastrointestinal cancers, intended for combination with CD3-engaging therapies.
Visit productCosigns Received
Be the first Cosign
Put your name behind ARC152.
Add it to your Products I use list and share why you use it.